Brands and Their Owners
Patent Number: 9387192
Patent Date: 2016-07-12
Patent type: utility
The present invention relates to a combined preparation comprising at least one rocaglamide derivative and at least one apoptosis inducing agent, preferably from the group of substances comprising agents inducing the extrinsic apoptotic pathway, antiproliferative agents and agents which induce apoptosis in T-cells by activation induced cell death (AICD) for the treatment of cancer.
Inventors
First Name | Last Name | City | State | Country |
---|---|---|---|---|
Peter H. | Krammer | - | - | - |
Min | Li-Weber | - | - | - |
IPCs
Section | Class | Sub Class | Group | Sub Group |
---|---|---|---|---|
A | 61 | K | 31 | 343 |
A | 61 | K | 39 | 395 |
A | 61 | K | 45 | 06 |
Assignee
Organization | First Name | Last Name | City | State | Country |
---|---|---|---|---|---|
DKFZ Deutsches Krebsforschungszentrum | - | - | - | - | - |